PHP47 EFFICIENCY IN DRUG PRESCRIPTION MEASURED BY THE APPLICATION OF ADJUSTED CLINICAL GROUPS IN THIRTEEN SPANISH PRIMARY CARE CENTRES  by Sicras-Mainar, A et al.
13th Euro Abstracts A413
± 109) (P = 0.025). Mean nursing home costs amounted to c3243 (±2700) per patient 
during the ﬁ nal month of life. Mean nursing home costs per patient of c3822 (±3232) 
for patients receiving usual care were higher than costs of c2456 (±2117) for patients 
receiving palliative care (P = 0.068). CONCLUSIONS: This study suggests that pallia-
tive care models in acute hospital wards and in nursing homes need to be supported 
because such care models appear to be less expensive than usual care and because 
such care models are likely to better reﬂ ect the needs of terminal patients.
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OBJECTIVES: To measure the efﬁ ciency of pharmacy resources utilization in 13 
Primary Care centres by the retrospective application of Adjusted Clinical Groups (ACG) 
in a usual clinical practice setting. METHODS: Retrospective study carried out on the 
basis of the clinical records from all the attended patients along the year 2008. Main 
variables: age, sex, case-mix/episodes, visits, pharmacy costs, 13 centres, physician and 
service (Family Medicine or Paediatrics). ACG grouper (Starﬁ eld and Weiner, Johns 
Hopkins University, n = 106) classiﬁ es each patient in a unique category of similar 
resource consumption. A Receiver Operating Characteristics (ROC-area under the 
curve) analysis was done to assess the predictive value of the model. The Efﬁ ciency Index 
(EI) was obtained as the quotient between the observed and the expected pharmacy 
costs according to ACG distribution (indirect standardization). The statistical package 
SPSS was used (P < 0.05). RESULTS: A total of 227,235 patients were included. Average 
number of episodes 4.5 ± 3.2 and visits 8.1 ± 8.2; mean age: 44.1 ± 23.7 years; and 
55.6% of males. Intensity of utilization: 77.4%. Costs of drug prescription: c70.6 mil-
lions (47.6% of the total costs). Mean cost was c310.8 ± 681.2. ROC curve analysis 
for episodes: 0.588 (p = 0.001); sensibility: 37.3%, speciﬁ city: 73.1% and intra-class 
correlation coefﬁ cient C: 0.732 (P < 0.001). The EI for each centre was analyzed, P < 
0.0001. Furthermore, differences between family physicians and paediatricians were 
observed (range: 0.55–1.46), P < 0.001. CONCLUSIONS: Results show a wide vari-
ability in the costs of pharmacy within centres and physicians. ACG provide an adjusted 
approximation to efﬁ ciency in pharmacy costs. Efﬁ ciency must not be considered as an 
isolated dimension of quality. The determination of the El could lead to a better knowl-
edge of the prescription proﬁ le from individual physicians and/or primary care teams.
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OBJECTIVES: Economic evaluation has been promoted as a tool to guide decision-
making processes regarding health care resources’ allocation and in the adoption of 
health care technologies. We analyzed the evolution and the main characteristics of 
economic evaluations of health care interventions done during the period 1983–2008 
in Spain. METHODS: Observational descriptive study. We performed a systematic 
review in the main bibliographic databases (PubMed/MEDLINE, SCOPUS, ISI Web of 
Knowledge, CRD, IME, IBECS) and manually through Internet in journals and public 
reports. There were predeﬁ ned inclusion and exclusion criteria, and a set of variables 
to analyze the characteristics of the selected reports. RESULTS: In total, 477 studies 
fulﬁ lled inclusion criteria. Some of the studies characteristics were: cost-effectivenes 
analysis (62.5%), decision analysis techniques (34.0%), heath care system perspective 
(42.1%), therapeutic interventions (70.0%) and non explicit ﬁ nancing (44.0%). The 
geographical distribution for Spanish regions of the ﬁ rst authors was: Catalonia 
(29.3%), Community of Madrid (23.7%), Andalusia (6.7%) and Region of Valencia 
(6.3%). a total of 50.9% of the principal authors were employed at hospital centers. 
The most commontly disease conditions were: cardiovascular diseases (15.7%), infec-
tious and parasitic diseases (15.3%) and malignant neoplasms (13.2%). a total of 82.2% 
of the reports provided recommendations guide for decision making. CONCLUSIONS: 
An increasing number of studies was observed. Identiﬁ ed reports combined heterogene-
ity in the quality of the information brought with regard to analysis methods, data 
sources, type of interventions, or disease conditions. It is suggested to do more efforts 
for improving the quantity and quality of reports in public health interventions.
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OBJECTIVES: The Chronic disease are ones of high prevalence, duration and slow 
progression, its cure could not be predicted clearly or will never be. In general, are 
related to lifestyles and population that is older. To determine the direct sanitary cost 
depending on chronic comorbidity grade (risk) in patients attended in a primary care 
setting (PC). METHODS: Retrospective multicentre design. Patients over 14 years 
were included, pertaining at 6 PC teams that demand assistance during year 2008. 
Main measures: sociodemographics, risk/casuistic/comorbidity, Charlson index (sever-
ity) and direct cost models. The chronic comorbidity was classiﬁ ed beginning from 
Adjusted Clinical Groups. It was obtained the Resources Utilization Bands (RUB) per 
patient (rank: 1- healthy user to 5- high morbidity). The complexity/comorbidity was 
grouped in 10 categories (6 expert forum). Fixed/semi ﬁ xed cost were considered 
(functioning: salary, services, purchases) and variable (tests, referrals, drugs). Explana-
tion power calculation: determination coefﬁ cient (R2). It was made an ANOVA analy-
sis for the correction (age, sex, comorbidity) of the models (procedure: Bonferroni). 
SPSSWIN program; P < 0.05. RESULTS: A total of 69,653 patients, age-average: 47.6 
± 18.8 years; women: 54.1%; high morbidity: 4.8%; chronic disease: 3.8 ± 2.3 and 
total cost: c51.3 million (ﬁ xed cost: 12.3%). The 35.4% (n = 24,670; CI: 34.5–36.3%) 
showed ≥5 chronic disease. Binary correlations: comorbidity-BUR: 0.716; cost-comor-
bidity: 0.596; age-comorbidity: 0.429; P < 0,001. Osseo-muscular illness (38.1%), 
mental (31.6%) and cardiovascular (30.4%) were the same frequencies, P < 0.001. 
The unitary average of the cost corrected was of c736.74 ± c921.97, with comorbidity 
ranks between: 1 = 309.62; 5 = 842.99; 10 = c2,354.05, respectively, P < 0.001. 
Predictive model (R2): age = 25.7%; age-sex = 26.5%; age-sex-comorbidity = 60.3%, 
of the cost. Women showed more comorbidity. CONCLUSIONS: Chronic comorbid-
ity is associated with a sanitary cost increase. The number of comorbidities explains 
the major part of the cost. Patient knowledge of risk/complexity enable us doing dif-
ferent strategies of preventive/cure intervention. KEY WORDS: comorbidity, cost, 
resource use, risk.
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OBJECTIVES: Austria’s health insurance system is divided into 13 sickness funds. 
Each fund has its own fee structure with individual names and codes for every pro-
cedure performed in an outpatient setting. Outpatient setting includes general practi-
tioners, specialists, ambulatories and institutes. Each sickness fund has general 
contracts for GPs and specialists while each institute has its own contract. These 
contracts partly include procedures that are not comparable with any procedures of 
other sickness funds. Some sickness funds pay physicians and institutes different fees 
for same procedures. Moreover, the payment depends on the number of procedures 
performed by a physician or institute within a certain period of time. In order to 
evaluate procedure data, the so called meta-fee-structure, a set of pre-deﬁ ned, stan-
dardized procedures that are mapped by individual fee-structures, was developed. 
METHODS: Given data with frequencies and costs of procedures for every sickness 
fund we are going to propose methods for examining and compare these data: Com-
paring the cumulative costs, frequencies, the average rates for procedures and the rates 
for different institutes and physicians paid by different sickness funds. All methods 
are then applied on real data in the ﬁ eld of radiology. RESULTS: By using this process 
with real world data it is possible to show the potential of these methods, lacks in 
data quality and the limitations of the meta-fee structure. Furthermore it is possible 
to point out proposals where procedure costs should be examined more closely and 
maybe health care costs could be reduced. CONCLUSIONS: Due to the heterogeneous 
health care system of Austria there is a wide variety of issues to be addressed when 
analyzing data. Although the proposed methods are very general they have to be 
adapted to the actual problems. Knowledge about data origin is crucial when choosing 
methods to get high quality results.
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OBJECTIVES: IV catheterization is the most common invasive procedure among 
hospitalized patients and the widest practiced to prevent complications is routine 
replacement of the catheter (RCC) in ﬁ xed intervals. a meta-analysis (Webster 2008) 
showed no signiﬁ cant differences in terms of efﬁ cacy from RCC and replacement only 
when clinically indicated (RCI). This study aims to compare costs and consequences 
of RCC versus RCI from the public payer perspective. METHODS: Efﬁ cacy data was 
obtained from Webster 2008 which showed no clinical beneﬁ ts of RCC over RCI. 
Data from the Brazilian Hospital Information System (SIH/DATASUS) from January 
1–December 31, 2009 was used to deﬁ ne the annual number of admissions of adult 
patients in public hospitals wards, assuming RCC as the current practice (no ICU 
patients included). The mean length of stay (LOS) and the mean time to replacement 
(TTR) were used to calculate the number of replacements in each scenario. Resource 
utilization was estimated through published data and unit costs were obtained from 
Brazilian ofﬁ cial price lists. RESULTS: A total of 8,985,758 hospitalizations were 
identiﬁ ed in the database in 2009 with mean LOS of 5.53 days (132.66 hours). 
According to a published randomized clinical trial included in Webster 2008, mean 
TTR for RCC and RCI was 66.5 and 90.6 hours, respectively, resulting in average 
1.99 and 1.46 replacements per hospitalization in each setting. The estimated cost of 
replacement was 2.54BRL (nursing time and medical supplies). For all admissions, the 
total cost for RCC and RCI was 45,556,510BRL and 33,438,277BRL. The estimated 
